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Abstract: 
While it may never be possible to accurately determine the effectiveness of a health promotion 
campaign, it seems clear that given adequate levels of funding, a healthy lifestyle promotion 
program should be capable of at least achieving a break-even level of effectiveness. 
 
Article: 
CORONARY HEART DISEASE (CHD) POSES A MAJOR burden, both in personal and 
economic terms, on health care management in North America. For example, CHD is the main 
cause of premature death and sickness among Canadians aged 35 to 64 years. Even when it does 
not result in mortality, heart disease still places a substantial burden on health care resources. For 
example, in 1990, 20 percent of hospital care days, or approximately 8 million days, were due to 
heart disease alone. The cost of treating heart disease topped C$16 billion in 1986 and has been 
on the rise ever since.
1
 Figures for the United States (U.S.) portray a similar picture.
2
 
Perhaps as a result of this, over the past two decades there has been widespread implementation 
of what have been termed “community-” or “population-” based CHD prevention programs, in 
the U.S., Canada and elsewhere. These primary prevention programs typically employ some 
combination of public education, social marketing, community mobilization, health-oriented 
public policy and environmental modification strategies in an effort to encourage target groups to 
adopt healthy lifestyle changes such as smoking cessation, dietary modifications and increased 
physical activity. The adoption of healthier lifestyles is, in turn, expected to prevent or forestall 
the onset of physiological risk factors which may subsequently lead to heart disease. The 
rationale for the population-based approach to heart disease prevention is based on the fact that 
when large segments of the general population are involved, even modest treatment effects (i.e., 
lifestyle changes) are likely to yield significant reductions in heart disease rates. Furthermore, 
from an economic perspective, the average or per capita cost of this approach is relatively low 
because there are neither case-finding nor individualized-treatment expenses. However, such 
programs have to be adopted and implemented with long-term prospects in mind. Although 
initial beneficial effects of such programs may start occurring soon after their initiation, studies 
have shown that it takes several years, anywhere upwards of five, for such behaviour 
modifications to reduce public health risk substantially.
3
 Nonetheless, such programs have 
received wide attention in the public health literature in the recent past,
4
 including criticism.
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The New Brunswick (N.B.) government’s Heart Health Promotion Program (NBHHP)
6
 is an 
example of one such heart health promotion campaign that adopts a primarily population-based 
approach, involving the mass media and several professional and community groups. The mass 
media are involved through the provision of advertising which encourages a lifestyle of 
nutritious food, exercise, moderate alcohol intake and abstention from tobacco use. Professionals 
and community organizations, such as physicians, teachers and the YMCA, are also involved in 
the program, by encouraging heart health promotion activities and offering programs that focus 
on heart health. 
 
Assuming that the Program has already been in place long enough for its behaviour modification 
effects to have started and to continue well into the future from the period of study, we analyzed 
the economic break- even efficacy of this model over a 12-year period. In other words, our 
economic analysis is based on a 12-year snapshot of an ongoing program that is in its “steady 
state.” Such a long time horizon of analysis was purposely chosen to improve the accuracy of our 
results, particularly in view of the gradual nature of the accrued benefits of a population-based 
prevention program. 
 
Notwithstanding the rationale for our time horizon, our approach focuses on first estimating the 
net savings to the Province of N.B. from this health promotion campaign in terms of treatment 
costs that are forgone and the savings that are made in productivity by workers taking fewer days 
off due to ill health. This estimation is done by our proposed model that utilizes various socio-
economic data from the Province as an input. Having predicted the net savings, we then compute 
the level of efficacy that this heart health promotion program would have to achieve for the 
future cost savings expected from the Program to break even with the costs of implementing the 
program. This estimated “break-even efficacy level” then serves as a basis for a qualitative 
assessment of the economic feasibility of the Program. 
 
In addition, we also propose a new model which uses the estimated break-even efficacy level to 
determine the optimal budget allocation for this heart health promotion program. Our primary 
conclusions from the study indicate that (a) heart health promotion campaigns are an extremely 
cost-effective way of controlling health care costs; and (b) given the assumptions of our 
optimization model, these campaigns are significantly underfunded in N.B. at this time. 
 
METHODOLOGY 
We began the study, modelled along the lines of the NBHHP, by estimating the maximum health 
and economic benefits possible from implementation of a 100 percent effective heart health 
promotion program in a target segment of the N.B. population. The period of study for this 
break-even analysis was assumed to be 12 years. Maximum health benefits, defined as the 
number of CHD cases which could be avoided over a 12-year period, were calculated using the 
Framingham CHD risk prediction model.
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 Maximum economic benefits were calculated by 
multiplying the estimated number of avoidable cases by the treatment and lost productivity costs 
associated with an average CHD case in N.B. Having determined the maximum economic 
benefits possible from a 100 percent effective CHD promotion program, we next developed a 
mathematical function which expresses potential cost savings from CHD prevention as a 
function of the heart health program’s effectiveness. Since a 100 percent effectiveness rate is 
almost always unachievable, this cost-effectiveness relationship was then used to determine the 
level of effectiveness that the heart health promotion program would have to achieve for 
potential cost savings from the Program to break even with its implementation costs. In keeping 
with standard economic practices, whenever future costs or savings were needed to be reduced to 
their present values, a discounting rate of five percent was used. 
 
Target population 
New Brunswick is a small province on Canada’s east coast, with a total population of 
approximately 760 000. The target population for CHD prevention programs typically consists of 
individuals between 30 and 74 years of age because CHD is rare in younger age groups and pri-
mary prevention efforts are less effective in the very elderly. In N.B., this 30- to 74-year-old 
target population includes approximately 360 000 individuals. A sample of 967 individuals (480 
males and 487 females) from this target population was derived from the 1989 New Brunswick 
Heart Health Survey (NBHHS) Report.
8
 This report is based on the NBHHS conducted in 1988 
which consisted of a stratified random sample of approximately 2000 N.B. residents between the 
ages of 18 and 74. It included a wide variety of heart health related knowledge, behaviour and 
physiological measurements as well as demographic information for each subject. The sample 
for the study consisted of all NBHHS participants who: (a) were between 30 and 74 years of age; 
(b) had no history of coronary heart disease; and (c) had records which included all of the 
physiological measures required by the Framingham risk equations. 
 
Calculation of maximum health benefits 
As a first step in estimating the maximum potential health benefit from a 100 percent effective 
heart health promotion program, the Framingham risk prediction model, as described by 
Anderson et al.,
9
 was used to calculate the expected incidence of CHD (i.e., number of new 
cases) in the target population over a 12-year period, assuming that the prevalence of major CHD 
risk factors remained at their 1988 levels. The Framingham model begins by calculating an 
individual risk score which is a function of each subject’s diastolic blood pressure (DBP), 
cigarette smoking (defined as smoking one or more cigarettes per day),10 ratio of total serum 
cholesterol to high density lipoprotein (HDL cholesterol), and history of left ventricular 
hypertrophy (LVH). In subsequent steps, the individual’s sex, age and history of diabetes are 
factored into the model. Finally, the desired time period (in this case 12 years) is entered into the 
equation and an estimate of that individual’s probability of developing CHD within the specified 
time period is calculated. After calculating a 12-year CHD morbidity estimate for each of the 967 
subjects, the sample results were extrapolated to the entire target population by multiplying each 
subject’s 12- year CHD morbidity estimate by the number of persons they represent in the target 
population, as obtained from the NBHHS. Summation of these weighted 12-year CHD morbidity 
probabilities provided an estimate of the number of persons in the target population who were 
likely to develop CHD over the 12-year observation period. 
 
The second step in estimating the maximum health benefit possible from a heart health 
promotion program involved modelling the effects that 100 percent adoption of recommended 
healthy lifestyle changes would likely have on the prevalence of major CHD risk factors in the 
target population. To calculate the impact of 100 percent adoption of heart healthy lifestyle 
changes, we began by identifying the healthy lifestyle changes that subjects in the target group 
could benefit from. Subjects were defined as being candidates for smoking cessation if they were 
regular smokers; candidates for dietary modification if they had a Body Mass Index (BMI) 
greater than 26; and candidates for increased physical activity if they did not engage in regular 
physical activity. Approximately 80 percent of the target population was identified as being 
candidates for one or more types of lifestyle change. Table 1 gives the percentages of the sample 
defined as being candidates for the various combinations of healthy lifestyle changes. 
 
Smoking cessation was defined as complete abstinence from cigarette smoking. Dietary 
modification was defined as adherence to a diet similar to that recommended by the American 
Heart Association in 1988
11
 – i.e., approximately 55 percent of total energy from carbohydrates 
and 30 percent from fat, with saturated fat reduced to 10 percent or lower, dietary cholesterol 
below 300 mg per day and sodium intake less than 3 g per day. Increased physical activity was 
defined as regularly 
 
engaging in activity of moderate intensity – i.e., enough to expend approximately 200 calories 
per day. We consulted the scientific literature to determine the probable effects that adoption of 
these healthy lifestyle changes would likely have on the modifiable CHD risk factors (i.e., 
smoking, diastolic blood pressure (DBP), diabetes, total and HDL cholesterol) in individual 
subjects. Since our model is intended to reflect the “probable” impact of voluntarily adopted 
healthy lifestyle changes in a target population, we generally utilized the more conservative 
estimates of the effects of the various lifestyle changes found in the clinical literature. 
 
In the third step of the post-behaviour-change morbidity calculation, subjects’ risk-factor levels 
were adjusted to reflect the estimated impact of 100 percent adoption of all recommended 
lifestyle changes. For example, all subjects who were regular smokers had their smoking status 
changed to that of a non-smoker; diastolic blood pressure was reduced in subjects who were 
identified as being candidates for dietary modification and/or increased physical activity; TCH 
(Total Cholesterol) was reduced in subjects who were identified as candidates for dietary 
modification and/or increased physical activity, and so on. The results of this modelling exercise 
yielded a “post-behaviour-change” risk-factor profile for the target population sample. Each 
individual’s new risk-factor profile was then entered into the Framingham equations and a 
second or postbehaviour-change estimate of CHD incidence in the target population was 
calculated using the weighting given in table 1. The maximum number of CHD cases which 
could be avoided through healthy lifestyle changes was determined by finding the difference 
between the first or prebehaviour-change CHD incidence estimate and the postbehaviour-change 
CHD incidence estimate. 
 
Calculation of maximum economic benefits 
The maximum economic benefits possible from implementation of a 100 percent effective heart 
health promotion program were calculated by estimating the annual treatment and lost 
productivity costs for an average CHD case in N.B. and then multiplying those cost figures by 
the number of years of symptoms which could be avoided if 100 percent of the target population 
were to adopt and maintain all recommended lifestyle changes. We calculated the treatment and 
lost productivity costs associated with CHD by following the approach that Wigle et al. 
developed to calculate the economic burden of cardiovascular disease in Canada. 
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 First, we 
estimated the total annual direct treatment costs due to CHD in N.B. Second, we estimated the 
prevalence of CHD in the 18- to 74-year-old population. This prevalence estimate was then used 
to calculate the average annual cost of treating an individual CHD case in N.B. Third, we 
estimated the total annual lost productivity costs associated with CHD. Lastly, we used the CHD 
prevalence estimate for the 30- to 64-year-old population to calculate the average annual lost 
productivity costs associated with an individual CHD case in N.B. 
 
RESULTS 
To apply the methodology discussed in the previous section to our model, we calculated the 
various input data for the target population in N.B. Then, we applied this data to a model that we 
developed for that population to predict the total savings to the Province as a function of the 
success rate of our health promotion campaign. As is typical of most pilot studies, the specific 
data for the province of N.B. was unavailable in one case; consequently, we extrapolated similar 
data available from a nationwide study. 
Maximum health benefits – As per the steps described above, the Framingham model was used 
to predict the number of CHD cases avoidable through the adoption of healthy lifestyle changes. 
We validated our results by comparing them against similar data available for the neighbouring 
province of Nova Scotia, whose socioeconomic profile is similar to that of N.B. Doing so, we 
found that the maximum number of CHD cases that could be avoided over the 12-year prediction 
period – if 100 percent of the target population adopted and maintained all recommended 
lifestyle changes – is: 
7166 cases over 12 years (1) 
We used the number defined in (1) for future calculations. However, before proceeding further, 
we noted a subtle, nonetheless important, assumption. Exactly how long it takes for individuals 
to realize the benefits of reduced heart health risk behaviour is largely dependent on the 
individuals themselves; this fact poses an analytical problem for any break-even study. To 
circumvent this problem, we performed a “steady-state analysis” of an ongoing heart health 
management program. In other words, we assumed that the intervention program has been in 
existence long enough to have actually started generating benefits at the beginning of the period 
of analysis and, further, that it will stay in existence well beyond the period of study. Hence, an 
individual case counted in the period of study may actually have been caused by behaviour 
modification adopted prior to the period of study. By the same token, there may be individuals 
whose behaviour modification during the period of study may actually accrue benefits only after 
the period of analysis. However, our assumption of performing a steady-state analysis of an 
ongoing program is used to “average out” such effects. 
Maximum economic benefits – Average annual treatment costs – We estimated the total 
annual cost of treating CHD in N.B. by calculating direct provincial government expenditures in 
four main cost categories identified by Wigle et al. 
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 As shown in table 2, the Province spends 
an estimated total of approximately C$44 million annually on CHD treatment. 
 
To arrive at an estimate of the average annual cost of treating one CHD case in the target 
population, the $43.9 million total cost figure was first adjusted to reflect only those costs which 
are likely to be associated with individuals under the age of 75. Information on hospital 
separations indicates that individuals over 75 account for approximately 30 percent of all 
hospital separations due to myocardial infarction in N.B.
14
 Therefore, we assumed that 
individuals over 75 account for 30 percent of the Province’s total annual CHD treatment costs 
and that individuals under that age account for the remaining 70 percent. This adjustment yields 
a total annual treatment cost of approximately $30.73 million for the under-75 population. Based 
on results from the NBHHS, we estimated that 8.9 percent (10.9 percent males and 
7.1 percent females) of the 30- to 74-year-old population (32 761 individuals) had some form of 
CHD which requires ongoing treatment. Dividing the adjusted total annual treatment cost figure 
$30.73 million by the estimated number of CHD cases in this age segment yields an: 
 
 
 
 
Since the treatment cost savings associated with avoiding the onset of CHD symptoms are 
expected to be realized over a 12-year period, it would typically be necessary to discount the 
future cost savings to reflect the fact that they will not accrue until some time in the future. 
However, on the basis of its past performance (for the past decade, the Consumer Price Index 
for health care has outpaced the average inflation rate by more than one percent per annum), the 
inflation rate for treatment costs is expected to be at least equal to the overall inflation rate. 
Hence, we did not discount the anticipated future cost savings in treatment of $938 per case. 
Average annual lost productivity costs – In addition to treatment costs, CHD also generates 
costs in terms of time lost from work as a result of short-term and chronic disability. Wigle et al. 
have calculated chronic and short-term disability costs for cardiovascular disease (CVD) in 
Canada.
15
 However, similar figures for CHD (a sub-component of CVD) are not available. To 
approximate short- and long-term disability costs associated with CHD, it was necessary to 
estimate what proportion of CVD disability costs are due to CHD. Approximately 38 percent of 
hospital separations due to CVD in N.B. are attributable to CHD.
16
 Therefore, the CHD 
disability costs were assumed to be approximately 38 percent of the corresponding CVD 
disability costs. To extrapolate the national cost estimate to N.B., the average annual lost 
productivity per Canadian worker due to CVD ($104.40) was multiplied by the size of the N.B. 
labour force (315 000 workers)
17
 to yield an estimate of the total annual lost productivity costs 
due to CVD of $32.57 million per year. To estimate the average lost productivity cost per CHD 
case in N.B., we then divided the lost productivity total for N.B. by the estimated number of 
CHD cases in the 30- to 64-year-old population
18
 as given by the census to obtain the: 
 
Model to predict net savings 
In the previous discussion, it is predicted that if our hypothetical heart health promotion 
campaign is 100 percent successful, then the total number of new CHD cases that would be 
avoided is 7166 over the 12-year intervention period (from (1)). Further, we also computed the 
average savings in treatment costs (in (2)) and lost productivity (in (3)) for each case of CHD 
avoided in N.B. We then used these socio-economic data as input to calculate the total savings 
that would accrue to the Province over the entire 12-year intervention period. The details of the 
computation will be described fIrst. Then, the entire series of computations is summarized in 
the form of a generalized model. 
 
We began by calculating the total savings in treatment costs accrued to the Province over the 
12-year intervention period. Note from (1) that 7166 CHD cases
19
 could be avoided over a 12-
year period if 100 percent of the target group adopted and maintained all the recommended 
healthy lifestyle changes. Assuming, as in Grover et al. ,20 that the occurrence of avoided cases 
is uniformly distributed over the 12-year prediction period, the predicted savings in treatment 
costs can be conceptualized as follows. We know that each case avoided saves $938. In 
addition, a 100 percent effectiveness will guarantee 7166 fewer cases over the 12-year 
intervention period, which translates to approximately 597 fewer cases annually for each of 
these 12 years. The 597 people who do not get sick in the first year of this 12-year period will 
save the Province $938/case for each of the 12 years of observation. The 597 cases avoided in 
the second year will similarly save $938 for the last 11 years of observation, and so on. Thus 
the total savings in treatment costs is: 
 
 
Next, we computed the total savings in productivity incurred by the Province over the entire 
intervention period. For this purpose, note that it has already been estimated in (3) that the loss 
in productivity/worker/ year is $2219. Further, in an effort to keep the estimate conservative, 
we only considered the 30 to 54 age group as being the ones that will contribute to the savings 
in productivity. The data from the application of the Framingham model described above 
showed that 2854 cases can be prevented over a 12-year period in the 30 to 54 age group. 
Assuming a provincial unemployment level of 15 percent
21
 (we deliberately chose a high figure 
to estimate the savings conservatively), 2426 cases of these represent employed people in 
whom the incidence of CHD is avoided. Thus, it is these 2426 cases that are assumed to 
generate the productivity savings over the 12-year period. As before, assuming a uniform 
distribution, about 202 cases will be avoided for each of the 12 years that will contribute to the 
productivity savings. 
 
By using the same argument as before, the 202 cases avoided in the first year will each generate 
a productivity savings of $2219 for each of the 12 years. Unlike treatment costs however, 
wages have not kept pace with inflation in Canada over the past decade. Thus, there is a need to 
use a discounting factor for the future savings obtained from the regained productivity. 
Assuming a discount rate of five percent, and that the productivity savings of any year are 
accrued at the end of the respective year, the total savings in productivity to the Province that 
these people generate is: 
 
 
Repeating computations such as (5) for each of the 12 years, it can be seen that if 100 percent 
of the targeted population switches to a healthier lifestyle, then the total savings in productivity 
that will be accrued to the Province over the entire 12-year period is: 
 
 
 
Hence, the total savings that might accrue over the 12-year prediction period can be easily 
estimated by adding together the two estimates (4) and (6) obtained above. Doing so, it can be 
seen that if 100 percent of the target population made all recommended healthy lifestyle 
changes, then: 
 
The estimated total cost savings of approximately $67.18 million is a purely hypothetical 
figure since in the real world we would never expect to see 100 percent adoption of healthy 
lifestyle changes in a target population. For example, an intervention program which is 50 
percent effective would be expected to generate half the cost savings; one that is 25 percent 
effective, only a quarter of that amount. Therefore, if the effectiveness (denoted as Δ) of a heart 
health promotion program is defined as the proportion of the target population which adopts 
and maintains recommended lifestyle changes, then the cost savings likely to be generated by 
such a program can be defined as below: 
 
 
 
 
 
 
The above procedure employed to produce (8) can also be generalized in the form of a simple 
mathematical model that can be used to do similar economic analysis for other heart health 
promotion campaigns in other populations.
22
 
Break-even analysis 
Unfortunately, it is extremely difficult, if not impossible, to estimate the effectiveness of 
population-based heart health promotion programs. However, by using the relationship between 
program effectiveness and potential cost savings described above, it is possible to estimate how 
effective our hypothetical intervention program would have to be to recoup the costs incurred 
to implement it (i.e., to break even). Like its counterparts in the other provinces, the NBHHP 
was jointly funded by Health Canada and the provincial Department of Health and Community 
Services over a period of five years. During its mandate, the NBHHP received an average of 
$400 000 per year in funding.
23
 Consequently, we conducted a break-even analysis with the 
assumption that our hypothetical 12-year intervention program also had an annual funding of 
$400 000. Assuming a time value of money of five percent, the present value of this stream of 
funding can be calculated as an annuity of $400 000 at five percent over 12 years, and the 
program implementation cost can be calculated as being equal to $6.37 million. If ΔBE denotes 
the break-even efficacy level of the health promotion campaign, then by setting this imple-
mentation cost equal to the expression for calculating potential cost savings in (8), we found 
that: 
 
So the break-even efficacy level of our hypothetical campaign is 9.48 percent over 12 years 
of operation or an annual effectiveness level of approximately 0.78 percent. In other words, on 
an annual basis, a program of this magnitude needs to motivate about 0.78 percent of its target 
audience to adopt and maintain all healthy lifestyle changes in order to break even. In our 
opinion, whereas the exactness of this number may be subject to debate, particularly in light of 
our assumptions and approximations, such a low value strongly conveys one conclusion. It 
underscores the fact that heart health promotion programs only need to effect relatively modest 
changes in their target populations to generate significant long-term cost savings. For example, 
to examine the feasibility of achieving this break-even level of success, we observed that the 
prevalence of regular smoking in N.B. declined by approximately five percentage points between 
1988 and 1995.
24
 It would appear that population behaviour changes of the magnitude necessary 
for heart health promotion programs to achieve break-even effectiveness are clearly feasible. 
 
Our conclusion is further corroborated by noting that in the present analysis we have only 
considered the impact of heart health promotion programs on treatment and lost productivity 
costs attributable to coronary heart disease. However, the healthy lifestyle behaviours targeted by 
heart health promotion programs also have a direct impact on the prevalence of numerous other 
diseases and conditions including many forms of cancer, cerebrovascular disease, hypertension 
and kidney disease, to name but a few. It is not at all unreasonable to suggest that for every 
dollar of cardiovascular disease treatment and lost productivity savings generated by a heart 
health promotion program, there will be additional savings in treatment and lost productivity 
savings associated with other lifestyle-related diseases and conditions. Therefore, when the broad 
impact of heart health promotion programs on lifestyle-related diseases and conditions is 
considered, it is not unreasonable to contend that the break-even effectiveness level may be even 
less than what is required for CVD alone. 
 
This suggests that heart health promotion programs offer an extremely economical means of 
combating both CVD and a host of other lifestyle-related conditions. Even if the impact of this 
type of population intervention program is very modest and difficult to distinguish from ongoing 
secular trends, our research suggests that it will still generate significant long-term cost savings. 
Optimal budget allocation 
Using the results of the preceding economic analysis, we developed a model for calculating the 
optimal level of funding for a heart health promotion program in N.B. We began with the most 
fundamental assumption of our model, namely, the relationship between the success rate of the 
campaigns and the budgets allocated to them. It is intuitively clear that as we allocate increasing 
sums of money to health promotion strategies, they can have a greater impact (i.e., their 
effectiveness may increase). These programs reach their audience through a variety of 
advertising media such as pamphlets, television and radio spots, advertisements in newspapers 
and popular magazines, and even through community activities. 
 
However, it is reasonable to expect that although increased exposure to the general public will 
initially increase the effectiveness of such campaigns, this increase will gradually taper off as the 
exposure level increases beyond a certain point. One reason for this possibility might be 
“advertising wear-out” of the targeted population – a phenomenon that is well-recognized in the 
marketing literature.
25
 Yet another reason for such diminishing returns could be that eventually 
these programs may reach their saturation level of effectiveness (i.e., that group of the targeted 
population that has the motivation and the discipline to change their lifestyles would have done 
so, leaving the others unchanged). 
 
Nonetheless, as the first step, we needed a precise mathematical expression that related the 
budget allocated to these programs to their final level of effectiveness. Further, this relationship 
should accurately mirror this behaviour of diminishing returns. We therefore assumed for our 
analysis that over the entire 12-year intervention period, if the total budget allocated to these 
health promotion campaigns were $B million, then the resulting level of effectiveness that could 
be achieved over the entire intervention period, that we denote Δ(B), is given as: 
 
The factor k refers to the Responsiveness Index of the targeted audience and measures how 
responsive this audience is to such campaigns. The higher the value of k, the lower will be the 
budget required to achieve a desired level of effectiveness. In other words, a high value of k will 
represent an audience that is highly receptive to health promotion campaigns, thereby making it 
easier for the Province to mold the behaviour of the targeted population through these 
campaigns. In practice, we would expect this responsiveness index to be determined primarily by 
the socio-economic characteristics of the targeted population such as education levels, income 
levels, etc., and to be outside the control of the agency responsible for implementing the health 
promotion campaigns. Based on these arguments, it was assumed to be a constant in our model. 
 
As an illustration, see figure 1 where the function Δ(B) has been shown for three values of k, 
namely, k = 0.5, 1 and 2. This demonstrates that for the same budget, a higher value of the 
responsiveness index guarantees a higher level of success. As a final point, note that for the 
results of (10) to be meaningful, the annual budget B must be at least (1/k) – hence, we assumed 
that this is always the case. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One of the key problems with using (10), however, is that the exact value of the responsiveness 
index (k) for the N.B. population is not known and may be difficult to measure. But, it can be 
estimated in the following simple way. As mentioned above, the assumed present level of 
funding for our program is $400 000 per year. At a discounting rate of five percent, this amounts 
to a total implementation cost of $6.37 million over the entire 12 year period; hence B = 6.37. If 
we let Δpresent denote the present level of effectiveness of our hypothetical campaign over the 
entire 12-year horizon of study, then by substituting the present value of B back into (10), we can 
see that for the N.B. population, the value of the responsiveness index is equal to: 
 
 
Thus, if a pilot study shows that the health promotion campaign in N.B. is only breaking 
even, i.e., its present level of effectiveness is 9.48 percent over the 12-year period, then, by (11), 
the responsiveness index for the targeted population in N.B. is equal to 0.1734. We then obtained 
a relationship between the optimal 12-year budget in millions of dollars, denoted by Bopt, and 
∆present. Note that the 12-year level of effectiveness, namely, Δ(B), is given by equation (10). 
Given that, some elementary mathematical operations
26
 allowed us to deduce that the optimal 12-
year budget was related to Δpresent in the following way : 
 
Based on this, we concluded that: 
 If the assumptions of our mathematical model were correct, then the optimal budget for a 
population- based heart health promotion program would be a decreasing function of its 
expected level of effectiveness. This stands to reason, since the more responsive the target 
population is, the less resources will be required to achieve a given level of program 
effectiveness. 
 The optimal budget for a heart health program such as NBHHP would be no higher than 
$20.68 million over a 12-year period. Discounted at a five percent rate, this amounts to a 
funding level of $1.3 million annually, or approximately $3.60 annually for each individual 
in the target population. By the definition of optimality, this is the budget amount that will 
maximize the program’s cost-effectiveness, i.e., generate the greatest cost savings per 
implementation dollar spent, when the responsiveness index of the population is very close to 
zero (i.e., the targeted audience is highly unresponsive). 
 Perhaps the most interesting observation from figure 2 is that the current annual budget of 
$400 000 of N.B.’s heart health promotion program is optimal only if the expected level of 
program effectiveness is very high, approximately 90 percent over the entire 12-year period. 
While the effectiveness level of population-based healthy lifestyle promotion programs in 
N.B. is unknown, it is virtually certain that such a high effectiveness rate is impossible. 
According to our model, this implies that NBHHP, with its funding of $400 000 per annum 
or approximately $1.10 annually for each individual in the target population, was 
significantly underfunded. For example, if the program is assumed to be only breaking even 
for the 12-year program scenario, i.e., Δpresent = 9.48 percent, then, by equation (12), the 
optimal budget for the Program should be about $1.23 million annually, or $3.40 per year for 
each individual in the target population. It can be verified that given a 12-year effectiveness 
rate of 9.48 percent and funding of $3.40 per person per year, the program would break even 
and still generate a net treatment and lost productivity savings of about $28.19 million over 
the 12-year intervention period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
There is very little information in the scientific literature concerning the cost of 
implementing effective population-based CVD prevention programs or their optimal levels of 
funding. Pearson et al.
27
 have suggested that a CVD prevention program could be mounted for 
about $0.75 per capita per year in developing countries where implementation costs are assumed 
to be much lower than in the industrialized world. Kottke et al.,
28
 drawing on information from 
the North Karelia Project
29
 have estimated that the cost of an effective population-based CVD 
prevention program in the U.S. is likely to be approximately $20 per person per year. Recent 
Canadian estimates
30
 suggest that population-based heart health promotion programs can achieve 
modest reductions in CHD risk factors at a cost per person of between $3 and $30 per year, 
depending on the level of intervention. Based on these estimates of probable implementation 
costs, the $3.40 per person per year funding level predicted by our optimization model appears to 
be close to the cost that we would expect to incur in order to implement a relatively low intensity 
population-based heart health promotion program designed to yield modest (i.e., break-even 
level) population lifestyle changes. 
Conclusions and recommendations 
In these days of increasing fiscal restraint, spending scarce health care dollars efficiently is one 
of the prime concerns of all levels of government and the health care industry. Since heart 
disease accounts for a substantial portion of the health care costs in Canada and the U.S., any 
savings resulting from a decreased CHD incidence would be of significant benefit. One way to 
reduce the incidence of heart disease is by primary prevention through population-based heart 
health promotion programs. However, the effectiveness of these programs has been difficult to 
evaluate, and although relatively inexpensive on a per capita basis, these programs still require a 
substantial investment which should be based on sound cost-effectiveness considerations. 
 
We have demonstrated a method of examining the potential cost effectiveness of a typical 
population-based heart health promotion program in N.B. and have attempted to quantify the 
level of effectiveness that such a program would have to achieve to make it a cost- effective 
health promotion strategy. Our analysis suggests two important conclusions: 
 
 It is clear from our study that population-based heart health promotion programs are a 
very cost-effective strategy for improving population health and reducing treatment and 
lost-productivity costs. Even at very modest levels of effectiveness, this type of program 
is capable of generating significant longterm cost savings. For example, our estimates 
show that in N.B., for every one percent of the 30- to 74- year-old target population 
which adopts and maintains a heart healthy lifestyle, the Province will save 
approximately $0.67 million in forgone treatment and lost-productivity costs over a 12-
year period. While it may never be possible to accurately determine the effectiveness of 
this type of health promotion program, it seems clear that given adequate levels of 
funding, a healthy lifestyle promotion program such as our 12-year program should be 
capable of at least achieving a break-even level of effectiveness (e.g., as little as 0.8 
percent annually) which will generate long-term cost savings sufficient to offset program 
implementation expenses. 
 If the assumptions of our mathematical budget optimization model were accurate, then 
the current level of funding for heart health promotion in N.B. (i.e., approximately $1 per 
individual in the target population) would be optimal only if the expected level of 
effectiveness of these programs is extremely high (approximately 90 percent). Since this 
is almost certainly not the case, it would appear that in all probability, heart health 
promotion is probably significantly underfunded in N.B., and that the Province could 
substantially increase its long-term treatment and lost-productivity cost savings by 
devoting more resources to heart health and healthy lifestyle promotion initiatives. Our 
theoretical model suggests that the optimal budget for an ongoing heart health promotion 
program in N.B. would be approximately $1.23 million annually or $3.40 per individual 
in the target population. 
 
As this is a first pass at this highly challenging and complex problem, there are numerous 
avenues for further research. Among the most immediate would be to fine-tune the optimization 
model and supplement it with more empirical work. Another interesting strand of future research 
could be to use the economic evaluation approach that we used to look at cost-effectiveness 
issues in other areas of health promotion and disease prevention. Although the results of this 
study apply specifically to the N.B. population, we believe that the same economic-evaluation 
strategy can be used, with minor modifications, to conduct similar studies on a wide range of 
health care-related issues where costs and savings can be estimated but treatment effects are 
difficult to quantify. 
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